Hey all, I just wanted to create a thread to discuss EOF's future.
EOF has high potential in the coming year as the legalization of OTC medicines is around the corner; they have put a lot of resources into clinical trials. I believe they are one of the frontrunners, bringing good revenue once approved.
The price is at all-time lows, and the companies profits have turned negative. Th
e company operating costs are 26mill per year, and cash reserves are almost empy.
I believe a Capital raising is around the corner to provide the capital to fund further research, marketing and phase 3 clinical trials.
This is just my opinion keen to hear others,GL everyone
Add to My Watchlist
What is My Watchlist?